| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8530944 | International Immunopharmacology | 2018 | 5 Pages |
Abstract
Receiving interferon beta-1a for >24â¯months is correlated with higher possibility of NAb production. The type of IFN-β used in the study had no significant impact on NAb positivity. In addition, both groups had comparable EDSS score changes, and NAb status of patients was correlated with their EDSS score.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Mahdieh Shokrollahi Barough, Fereshteh Ashtari, Mehdi Sadat Akhavi, Nabiollah Asghari, Ghasem Mosayebi, Majid Mirmohammadkhani, Naser Kokhaei, Farhad Bahraminia, Arman Ajami, Parviz Kokhaei,